RBS (LON:RBS)‘s stock had its “neutral” rating reissued by investment analysts at Macquarie in a research report issued on Wednesday. They presently have a GBX 190 ($2.37) price objective on the financial services provider’s stock. Macquarie’s target price points to a potential downside of 5.71% from the company’s previous close.
Several other research analysts have also weighed in on the company. Deutsche Bank AG boosted their price target on RBS from GBX 171 ($2.14) to GBX 172 ($2.15) and gave the stock a “sell” rating in a research report on Wednesday, November 2nd. Barclays PLC lowered their price target on RBS from GBX 200 ($2.50) to GBX 175 ($2.19) and set an “underweight” rating on the stock in a research report on Monday, October 31st. Investec lowered RBS to a “sell” rating in a research report on Monday, October 24th. BNP Paribas reaffirmed a “neutral” rating and set a GBX 180 ($2.25) price target on shares of RBS in a research report on Tuesday, October 4th. Finally, Royal Bank Of Canada reaffirmed an “underperform” rating and set a GBX 150 ($1.87) price target on shares of RBS in a research report on Tuesday, October 4th. Eight analysts have rated the stock with a sell rating, nine have given a hold rating and five have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of GBX 232.50 ($2.90).
Shares of RBS (LON:RBS) traded down 0.837% on Wednesday, reaching GBX 201.415. The company had a trading volume of 8,569,970 shares. The company’s 50-day moving average price is GBX 191.60 and its 200-day moving average price is GBX 198.16. The firm’s market capitalization is GBX 23.67 billion. RBS has a 52-week low of GBX 148.40 and a 52-week high of GBX 315.70.
In related news, insider Ross McEwan purchased 141,363 shares of the firm’s stock in a transaction dated Tuesday, November 8th. The stock was bought at an average price of GBX 187 ($2.34) per share, with a total value of £264,348.81 ($330,270.88).